Discover

RCKT
Rocket Pharmaceuticals, Inc.
3.52
18 x 3.50
9 x 3.51
bid
ask
-
0.13
3.43%
12:37 PM
timesize
Ytd0.14%
1y20.38%
3.37
day range
3.67
2.53
52 week range
5.45
Open3.65Prev Close3.64Low3.37High3.67Mkt Cap382.72M
Vol873.62KAvg Vol2.38MEPS-1.84P/E-1.90Forward P/E-3.35
Beta0.47Short Ratio7.72Inst. Own106.93%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg3.32200-d Avg3.561yr Est40.93

RCKT News

Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
businesswire.com
Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

Rocket Pharmaceuticals Touts Positive Early Safety Data from Revised Genetic Therapy Trial
benzinga.com
Rocket Pharmaceuticals Touts Positive Early Safety Data from Revised Genetic Therapy Trial

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) on Monday shared a clinical safety update concerning the

Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease
gurufocus.com
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated

[url="]Rocket Pharmaceuticals, Inc.[/url] (Rocket or the Company) (NASDAQ: RCKT), a fully integrated

Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease
businesswire.com
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (Rocket or the Company) (NASDAQ: RCKT)

9 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
9 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers American Shared Hospital (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
businesswire.com
Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher f

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

Rocket Pharmaceuticals, Inc. (RCKT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com
Rocket Pharmaceuticals, Inc. (RCKT) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

Rocket Pharmaceuticals, Inc. (RCKT) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

Rocket Pharmaceuticals, Inc. (RCKT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
seekingalpha.com
Rocket Pharmaceuticals, Inc. (RCKT) Presents at Jefferies Global Healthcare Conference 2026 Transcri

Rocket Pharmaceuticals, Inc. (RCKT) Presents at Jefferies Global Healthcare Conference 2026 Transcri

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
businesswire.com
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus
zacks.com
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus

Rocket Pharmaceuticals shares fell after a wider-than-expected Q1 loss as the company focuses on the

Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
businesswire.com
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
businesswire.com
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, co

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
zacks.com
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

Rocket Pharmaceuticals drops despite the FDA's accelerated approval of gene therapy Kresladi in seve

Contrasting Foghorn Therapeutics (NASDAQ:FHTX) and Rocket Pharmaceuticals (NASDAQ:RCKT)
defenseworld.net
Contrasting Foghorn Therapeutics (NASDAQ:FHTX) and Rocket Pharmaceuticals (NASDAQ:RCKT)

Foghorn Therapeutics (NASDAQ: FHTX - Get Free Report) and Rocket Pharmaceuticals (NASDAQ: RCKT - Get

Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 Transcript
seekingalpha.com
Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leuko

Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leuko

Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI
proactiveinvestors.ca
Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI

Rocket Pharmaceuticals (NASDAQ:RCKT) announced that the US Food and Drug Administration (FDA) has gr

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Rocket Pharma shares climb as FDA approves first therapy for deadly childhood disorder
reuters.com
Rocket Pharma shares climb as FDA approves first therapy for deadly childhood disorder

Rocket Pharmaceuticals shares jumped 10% on Friday before the bell after the U.S. Food and Drug Admi

Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
businesswire.com
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukoc

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated bio

Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI
proactiveinvestors.com
Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI

Rocket Pharmaceuticals (NASDAQ:RCKT) announced that the US Food and Drug Administration (FDA) has gr

Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
seekingalpha.com
Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcri

Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcri

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
zacks.com
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

Rocket Pharmaceuticals reports narrower-than-estimated Q4 loss. The company provides key updates on

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market S

FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
benzinga.com
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy

William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty i

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Nordson Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Nordson Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com
Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings
benzinga.com
Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  Wednesday's session saw 784 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 431 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 242 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 671 companies achieved new lows for the year.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  During Friday's session, 445 companies made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

benzinga.com
Stocks That Hit 52-Week Highs On Friday

Stocks That Hit 52-Week Highs On Friday

benzinga.com
41 Biggest Movers From Yesterday

41 Biggest Movers From Yesterday

benzinga.com
Stocks Which Set New 52-Week High Friday, September 14th

Stocks Which Set New 52-Week High Friday, September 14th

benzinga.com
Stocks Which Set New 52-Week High Yesterday, September 13th

Stocks Which Set New 52-Week High Yesterday, September 13th

benzinga.com
Stocks Which Set New 52-Week High Yesterday, September 11th

Stocks Which Set New 52-Week High Yesterday, September 11th

benzinga.com
24 Stocks Moving In Tuesday's Pre-Market Session

24 Stocks Moving In Tuesday's Pre-Market Session